EC
EcoR1 Capital’s Janux Therapeutics JANX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34M | Hold |
1,469,818
| – | – | 2.01% | 12 |
|
|
2025
Q1 | $39.7M | Hold |
1,469,818
| – | – | 2.35% | 11 |
|
|
2024
Q4 | $78.7M | Hold |
1,469,818
| – | – | 2.98% | 10 |
|
|
2024
Q3 | $66.8M | Hold |
1,469,818
| – | – | 2.29% | 11 |
|
|
2024
Q2 | $61.6M | Buy |
+1,469,818
| New | +$61.6M | 1.88% | 15 |
|
|
2023
Q3 | – | Sell |
-452,590
| Closed | -$5.37M | – | 53 |
|
|
2023
Q2 | $5.37M | Sell |
452,590
-3,385,896
| -88% | -$40.2M | 0.13% | 37 |
|
|
2023
Q1 | $46.4M | Buy |
3,838,486
+2,417,167
| +170% | +$29.2M | 1.5% | 15 |
|
|
2022
Q4 | $18.7M | Hold |
1,421,319
| – | – | 0.57% | 30 |
|
|
2022
Q3 | $19.2M | Hold |
1,421,319
| – | – | 0.57% | 28 |
|
|
2022
Q2 | $17.4M | Hold |
1,421,319
| – | – | 0.6% | 30 |
|
|
2022
Q1 | $20.4M | Buy |
1,421,319
+9,344
| +0.7% | +$134K | 0.64% | 30 |
|
|
2021
Q4 | $27.9M | Hold |
1,411,975
| – | – | 0.89% | 23 |
|
|
2021
Q3 | $30.5M | Hold |
1,411,975
| – | – | 1.06% | 18 |
|
|
2021
Q2 | $35.2M | Buy |
+1,411,975
| New | +$35.2M | 1.32% | 16 |
|